VivoPath

VivoPath is a specialized preclinical contract research organization (CRO) providing advanced in vivo imaging and pathology services to the biopharmaceutical industry. Founded in 2018 and headquartered in Worcester, Massachusetts, the company offers high-resolution longitudinal imaging, toxicology, and histopathology to accelerate drug discovery. VivoPath was acquired by Inotiv in July 2021, integrating its expertise in translational imaging and pathology into Inotiv's broader suite of drug development services. The company's capabilities allow for the real-time monitoring of disease progression and therapeutic efficacy in animal models across therapeutic areas such as oncology and inflammation.